CeDLara: Phase 3 Study for Celiac Disease
The CeDLara Study is for adults who have been diagnosed with celiac disease and are still experiencing symptoms despite following a gluten-free diet.
Continue ReadingThe CeDLara Study is for adults who have been diagnosed with celiac disease and are still experiencing symptoms despite following a gluten-free diet.
Continue ReadingLatiglutenase is a dual enzyme investigational product designed to break down gluten in the stomach. Learn more about the trial and what this means for celiac disease patients.
Continue ReadingUkko, a startup focused on eradicating food allergies, intolerances, and sensitivities, has reached a promising stage in its effort to develop a gluten specifically designed for people with celiac disease.
Continue Reading9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment.
Continue ReadingAnokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingRep. Betty McCollum (D-MN) and Rep. Steve Stivers (D-OH) announced the formation of the Congressional Celiac Disease Caucus at the 2021 Celiac Disease Foundation Patient Education & Advocacy Summit.
Continue ReadingWith your help, we have invested significant resources into changing that reality in Washington, DC, and we are beginning to see a return on that investment.
Continue ReadingThank you to Glutenostics for sponsoring our upcoming Patient Education and Advocacy Summit. Through the licensing, development, and commercialization of novel technologies, Glutenostics is bringing new tools to market that address the unmet needs of millions of Americans avoiding gluten for health concerns. Register now to be a part of this monumental event!
Continue ReadingThank you to Provention Bio, Inc., for supporting our upcoming Patient Education and Advocacy Summit. Provention Bio, Inc., is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. Register now to be a part of this monumental event!
Continue Reading